724 reports of this reaction
3.6% of all Advair reports
#2 most reported adverse reaction
PNEUMONIA is the #2 most commonly reported adverse reaction for Advair, manufactured by GlaxoSmithKline LLC. There are 724 FDA adverse event reports linking Advair to PNEUMONIA. This represents approximately 3.6% of all 20,040 adverse event reports for this drug.
Patients taking Advair who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is moderately reported among Advair users, representing a notable but not dominant share of adverse events.
In addition to pneumonia, the following adverse reactions have been reported for Advair:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 724 FDA reports for Advair. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 3.6% of all adverse event reports for Advair, making it one of the most commonly reported side effect.
If you experience pneumonia while taking Advair, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.